DiaSorin (OTCMKTS:DSRLF) Shares Gap Up – Here’s What Happened

DiaSorin S.p.A. (OTCMKTS:DSRLF) gapped up prior to trading on Monday. The stock had previously closed at $84.12, but opened at $92.00. DiaSorin shares last traded at $92.00, with a volume of 226 shares.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on DSRLF. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of DiaSorin in a report on Tuesday, August 4th. BNP Paribas Exane cut shares of DiaSorin from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 7th. UBS Group downgraded shares of DiaSorin from a “hold” rating to a “sell” rating in a research report on Wednesday, August 12th. Finally, Zacks Research raised shares of DiaSorin from a “strong sell” rating to a “hold” rating in a research report on Friday, October 2nd. Two research analysts have rated the stock with a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, DiaSorin currently has an average rating of “Strong Sell”.

DiaSorin Price Performance

The stock has a 50-day moving average of $85.86 and a 200 day moving average of $79.20.

DiaSorin Company Profile

DiaSorin S.p.A. is an Italian company specializing in in vitro diagnostics, with a focus on immunodiagnostics and molecular diagnostics. Its products are used by hospitals, clinical laboratories and healthcare providers to support the detection, diagnosis and monitoring of a range of diseases and medical conditions.

The company’s portfolio includes automated immunoassay systems, reagents and diagnostic tests marketed under the LIAISON family, as well as molecular diagnostic platforms and assays.